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Previous studies from this and other laboratories (1-5)  have established that 
the antibody response of mice to the so-called thymus independent (TI) 1 antigen 
type III pneumococcal polysaccharide ($3) is strongly influenced by regulatory 
T  cells such as suppressor  T  cells (Ts)  and amplifier T  cells (Ta).  Like other 
polysaccharide antigens,  $3  was  shown  to  be  a  potent  tolerogen  in  mice;  in 
addition, tolerance induced either by low doses of $3 (low dose paralysis) (5) or 
by $3 coupled to syngeneic spleen cells (S3-SC) (6) was dependent on the presence 
of T  lymphocytes. Although those observations suggested that tolerance induced 
by $3 or S3-SC might be mediated by Ts, T  cells obtained from mice given $3 
or S3-SC several days or weeks previously did not suppress the antibody response 
to  $3  after  transfer  to  normal  mice  (2,  7,  8).  Subsequent  studies,  however, 
indicated that S3-specific Ts could be detected in  mice given S3-SC  (8-10)  or 
low doses of $3 (7,  1 1) but only under very defined conditions. For example, T 
cells from mice given low doses of $3  were able to suppress the $3 response if 
the cells were transferred within 6-24 h after the donors were injected with $3 
(7). Cells transferred at later times, 3-7 d after injection of $3, did not suppress 
the response (7) but rather were able to augment it (1 1). Cells from mice injected 
with S3-SC were able to suppress the $3 response after transfer if donors were 
given cyclophosphamide (Cy) before injection of S3-SC (10) or if cells from mice 
given S3-SC were cultured in vitro with $3 and a soluble membrane component 
of S3-SC (S3-SCSM) before transfer (8, 9). 
The fact that $3 and S3-SC did indeed activate Ts but that the Ts could only 
be demonstrated under defined and rather unusual conditions suggested that $3 
and S3-SC  also activated a  second type of cell  which could interfere with the 
activity of Ts.  T  cells with  the ability to  interfere with Ts activity have  been 
previously described (12) and have been termed contrasuppressor T  cells (Tcs). 
The present studies were initiated in an attempt to determine if Tcs might be 
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detectable  in  mice  injected  with  S3-SCSM.  Tcs  were  found  in  such  mice  and 
some of the properties  of these cells are described below. 
Materials  and  Methods 
Mice.  CAF~  female  mice,  8-12  wk old,  were  used  for all  experiments.  They were 
obtained from The Jackson Laboratories, Bar Harbor, ME. BALB.B mice were raised in 
our breeding colonies at the University of Missouri. 
Preparation of S3-SC.  $3  was coupled to normal CAF~  or BALB.B spleen  cells with 
chromic chloride as previously described (6).  Mock SC were treated with chromic chloride 
alone. S3-SCSM, prepared by freeze-thawing S3-SC four times followed by centrifugation 
at 10,000 g to remove debris (8), was used for all experiments.  Mock SCSM was prepared 
in the same way using mock SC. 
Induction  and Assay  to Ts.  Mice  were injected  intraperitoneally  with  100  mg/kg Cy 
(Cytoxan; Mead Johnson & Co, Indianapolis,  IN) and 2 d  later were given mock SCSM 
or S3-SCSM (amount equivalent to 5 ×  107 SC). 8 d later, 5 ×  106 spleen cells from these 
donor mice were transferred intravenously to syngeneic recipients which were immunized 
4-6  h  later  with  0.6  #g $3  (10).  In one  experiment,  S3-specific  Ts  were  induced  by 
injecting mice intravenously with S3-SCSM.  5 d  later spleen cells from these mice were 
cultured in vitro for 48 h  with mock SCSM (controls) or $3 plus S3-SCSM as previously 
described  in  detail  (8).  5  x  106  control  or Ts  cells  were  transferred  intravenously  to 
syngeneic recipients which were immunized the following day with 0.6/~g $3 (8,  9).  S3- 
specific plaque-forming  cells  (PFC)  were  enumerated  5  d  later  in  all  experiments  (8). 
Previous studies have shown that S3-specific Ts induced by the two methods described 
above belong to different T  cell subsets (9). 
Induction and Assay of Tcs.  Mice were injected intravenously with S3-SCSM (amount 
equivalent to 5 ×  10"SC). 8 d  later spleen cells from these mice were separated on plates 
coated with the lectin Vicia villosa  (V.v.) (E. Y.  Laboratories, San Mateo, CA) as described 
in detail below. Cells which adhered to V.v were mixed with either of the Ts populations 
described above just before intravenous injection (5 x  106 V.v.-adherent cells and 5 ×  10  ~ 
Ts).  In  some  experiments,  V.v.-adherent  cells  were  treated  with  various  antisera  and 
complement (C) before transfer (see below). Other cell populations that were tested for 
Tcs activity in some experiments included V.v.-nonadherent cells from mice given S3-SC 
8 d previously or V.v.-adherent cells from mice given mock SCSM or Cy plus S3-SCSM 8 
d previously. 
Separation  of Spleen  Cells on V.v. Plates.  Spleen cells were separated on V.v. essentially 
as described  by Iverson  et  al.  (13).  Briefly,  V.v.  diluted  to  500  ~g/ml  in  saline  citrate 
buffer,  pH  5.5,  was added  to  100-mm  tissue  culture  grade  petri  plates  (Falcon  3003; 
Falcon  Labware,  Oxnard,  CA) for 45-60  min at room temperature.  The V.v.  solution 
was removed, plates were washed twice in pH 7.2 phosphate-buffered saline, and balanced 
salt solution (BSS) containing 2-3 % fetal calf serum (FCS) was then added for 10-15 min. 
Spleen cells (10  x  106/ml in  BSS/FCS were then added (6-7 ml/plate) and plates were 
incubated at 37 °C for 45 min. Cells nonadherent to the plates were removed after gentle 
swirling of the plates and plates were rinsed  one or twice in  BSS. Cells adherent to the 
plates  were  eluted  by adding  5  ml  BSS  containing  1  mg/ml  N-acetyI-D-galactosamine 
(Sigma  Chemical  Co.,  St.  Louis,  MO)  and  incubating  the  plates  5-10  min  at  37°C. 
Adherent cells were then removed by vigorous pipetting. Cells were washed once in BSS 
and counted. Generally, 50-60% of the spleen cells were recovered as nonadherent cells 
and  15-25% as adherent cells. 
Antiserum Treatment.  For some experiments,  V.v.-adherent spleen  cells were treated 
with anti-Thy-l.2, anti-Lyt-2.2, anti-Lyt-l.2, or anti-I-J  b and C before use.  The prepara- 
tion, activity, and specificity of the anti-Lyt antisera were described previously (14). Anti- 
Thy-l.2  was  ascites  from  mice  injected  with  the  anti-Thy-l.2  hydridoma  HO  13.4, 
obtained  from  Dr.  Michael  Misfeldt,  University  of Missouri.  The  monoclonal anti-I-J  b 
reagents WF9.40.5 and WF9.1.4 were kindly supplied by Dr. Carl Waltenbaugh,  North- 
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(SE) system while WF9.40.5  is cytotoxic for Ts but not for Tcs (D. R. Green, personal 
communication). The culture supernatants containing these monoclonals were used at a 
final concentration  of 1:50.  Cells were treated with  antiserum and  low toxicity rabbit 
complement by a two-step cytotoxicity procedure (14). 
PFC Assay.  IgM PFC were enumerated as previously described (8) using $3 coupled 
to sheep erythrocytes (S3-SE) as indicator cells (15).  Results are presented as PFC/spleen 
but the conclusions would not differ if results were expressed as PFC/106 spleen cells. 
Results 
Mice Injected with S3-SCSM Have Cells that Interfere with Ts Activity.  Previous 
studies (10) from this laboratory have shown that S3-specific Ts could be induced 
by S3-SCSM in Cy-treated mice but not in normal mice (10).  Similarly, the data 
shown in groups A-C of Table I illustrate that spleen cells from Cy-treated mice 
injected with S3-SCSM (group B) are able to suppress the IgM PFC response to 
$3  whereas  cells  from  mice  given  S3-SCSM  but  no  Cy  (group  C)  have  no 
detectable suppressor activity. The suppressor cells induced  in Cy-treated mice 
with S3-SCSM have been previously described and are S3-specific Lyt-l-2  ÷, I-J  + 
T  cells  (9,  10).  The  necessity  to  treat  mice  with  Cy  to  obtain  detectable  Ts 
suggested  that  a  Cy-sensitive cell  which  could  interfere  with  the  activation  or 
expression of Ts in this system might be present in normal mice given S3-SCSM. 
Cells with the ability to interfere with Ts function, i.e., Tcs, have been shown by 
others to be adherent to V.v.  (13,  16).  If spleen cells from normal mice injected 
with  S3-SCSM  do  contain  Tcs,  V.v.-adherent  cells  from  those  mice should  be 
able to abrogate the function of the Ts induced in Cy-treated mice. To investigate 
this  possibility,  spleen  cells  from  normal  mice  given  S3-SCSM  8  d  previously 
were separated  on  V.v.  plates and  the  V.v.-adherent  and  -nonadherent  cells or 
unseparated  cells  from  these  mice  were  mixed  with  an  equal  number  of Ts 
induced  in Cy-treated mice. The ability of these Ts to suppress the response to 
$3  (group B  in  Table I) was not affected by spleen cells from donors  given Cy 
and mock SCSM  (group D) or by unfractionated  spleen cells (group E) or V.v.- 
nonadherent  cells (group F) from mice given S3-SCSM.  By contrast,  V.v.-adher- 
ent  cells  from  mice  given  S3-SCSM  almost  completely abrogated  Ts  activity 
TABLE  I 
V.v.-adherent Spleen Cells from Mice Given S3-SCSM Have Contrasuppressor Activity 
Donor mice given:*  Cells transferred*  $3 PFC/spleen 0 
A.  Cy + mock SCSM  A  13,875 4- 1,451 
B.  Cy +  S3-SCSM (Ts control)  B  7,680 __- 1,428 (45) 
C.  S3-SCSM  (no Cy)  C  16,050 __- 2,415 (0) 
D.  A + B  4,425 4- 542  (69) 
E.  B + C  6,144 4- 759  (56) 
F.  B + V.v. nonadherent  of C  5,356 -+ 597  (62) 
G.  B + V.v. adherent of C  13,175 __- 1,789 (7) 
* CAF~ mice were given 100 mg/kg Cy 2 d before mock- or S3-SCSM (A and B). Group C received 
S3-SCSM and no Cy. 8 d later, spleen cells were removed and transferred  as indicated to normal 
CAF1 recipients which were immunized 4 h later with 0.6 gg $3. 
* 5 × 106 cells of each type per recipient. 
Mean PFC/spleen 4- SEM of four to five mice per group 5 d after immunization. The percent 
suppression relative to group A (positive control) is given in parentheses. BRALEY-MULLEN  45 
(group G vs. group B in Table I). The results suggest that cells from normal mice 
injected with S3-SCSM have the ability to interfere with S3-specific Ts activity. 
The necessity to separate the spleen cells on V.v.  to demonstrate the contrasup- 
pressor activity (group E vs. group G) may be due to the fact that the contrasup- 
pressor cells in the unfractionated spleen cells are 'neutralized' by Ts present in 
the same spleen cell population (see below). 
Not All V.v.-adherent Cells Have Contrasuppressor Activity.  The results in Table 
I  established that  V.v.-adherent cells from mice injected with  S3-SCSM  could 
interfere with Ts activity but that unfractionated or V.v.-nonadherent cells did 
not interfere with Ts activity.  Before concluding that S3-SCSM  induced cells 
with contrasuppressor activity, it was important to establish that all V.v.-adherent 
spleen cell populations  did not have this activity. Therefore spleen cells from 
normal CAF1 mice or from mice given S3-SCSM or polyvinylpyrrolidone-coupled 
SCSM (PVP-SCSM) 8 d previously were separated on V.v.  and the V.v.-adherent 
fractions  were  each  mixed  with  an  equal  number  of Ts  as  in  the  previous 
experiments (Table  II).  As before, the  V.v.-adherent cells from mice injected 
with S3-SCSM almost completely abrogated the ability of the Ts to suppress the 
$3 response (group D vs. group B). By contrast, V.v.-adherent cells from normal 
mice (group E) or from mice injected with PVP-SCSM (group F) had no effect 
on Ts activity. Thus cells with the ability to  interfere with S3-specific Ts are 
apparently induced by S3-SCSM. 
Contrasupressor Cells Are Not Present in  Cy-treated  Mice  Given S3-SCSM.  We 
previously suggested (10) that the ability to induce S3-specific Ts with S3-SCSM 
in Cy-treated mice but not in normal mice was due to the fact that cells which 
interfered with Ts activity were eliminated by Cy, thus allowing Ts activity to be 
expressed. To directly test this possibility, spleen cells from both normal and Cy- 
treated mice given S3-SCSM 8 d previously were separated on V.v.  and the V.v.- 
adherent cells were mixed with an equal number of unfractionated spleen cells 
TABLE  II 
Not All V.v.-adherent Cells Have Contrasuppressor Activity 
Donor mice given:*  Cells transferred* 
$3 PFC/spleen  m 
Exp.  1  Exp. 2 
A.  Cy +  mock SCSM  A  14,667 _+ 2,763  12,523 +  2,486 
B.  Cy +  S3-SCSM (Ts  B  6,200 +  470  (58)  3,356 _  443 
control) 
C.  S3-SCSM (no Cy)  C  9,163 _  1,902 (38)  ND 
(74) 
D.  B + V.v. adherent of C  11,675 +_ 1,183 (20)  9,350 _  1,632 (26) 
E.  B +  V.v.-adherent  5,590 _  988  (62)  3,300 _  750  (75) 
normal 
F.  B +  V.v.-adherent PVP-  ND  4,433 _  733  (65) 
SCSM 
* See footnote * in Table I for experimental design. 
* 5 x  10  6 cells of each type per recipient. In group E, the V.v.-adherent cells were from normal CAF~ 
mice and in group F, they were from CAFt mice injected 8 d previously with PVP-SCSM. 
Mean PFC/spleen + SEM of 5-12 mice per group determined 5 d after immunization. The percent 
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from Cy-treated mice given S3-SCSM (Ts control) (Table III). As in the previous 
experiments,  V.v.-adherent  cells from mice given S3-SCSM and no Cy (group D) 
abrogated the ability of Ts to suppress the $3 response. By contrast, V.v.-adherent 
cells  from  mice  given  the  same  S3-SCSM  and  Cy  (group  E)  were  unable  to 
interfere with Ts activity, suggesting that cells with contrasuppressor activity are 
Cy sensitive. 
Removal of Contrasuppressor  Cells Reveals  Ts Activity in Cells from Mice Injected 
with S3-SCSM.  Having established  that  mice  injected  with  S3-SCSM  have cells 
which  can  interfere  with  the activity  of Ts  induced  by S3-SCSM  in  Cy-treated 
mice, it was of interest to determine whether the contrasuppressor cells prevented 
the activation of Ts or merely prevented their expression. To begin to assess this 
question,  we asked whether the removal of contrasuppressor  cells from a  spleen 
cell  population  would  enable  the  remaining  cells  to suppress  the  $3  response. 
Therefore  mice were  injected  with  S3-SCSM  or with  mock SCSM as a  control. 
8  d  later  spleen  cells from the  mice given S3-SCSM  were separated  on V.v.  and 
the  various  unseparated  or  separated  cell  populations  were  injected  into  mice 
that were then  immunized  with  $3.  The  results  of two experiments  of this  type 
are shown  in Table  IV.  As shown  previously (see above),  unfractionated  spleen 
TABLE  III 
Contrasuppressor  Cells Are Not Present in Cy-treated Mice 
Donor mice given:*  Cells transferred*  $3 PFC/spleen 0 
A.  Cy + mock SCSM  A  13,250 4- 2,106 
B.  Cy + S3-SCSM (Ts Control)  B  6,111  4- 833  (54) 
C.  S3-SCSM  (no Cy)  C  9,683 4- 659  (27) 
D.  B + V.v. adherent of C  13,321 4- 907  (0) 
E.  B + V.v. adherent of B  5,575 _  999  (58) 
* See footnote * in Table I for experimental  design. 
* 5 ×  l0  s cells of each type per recipient. 
§ Mean PFC/spleen  -  SEM of 4-10 mice per group determined 5 d after immunization.  The percent 
suppression relative to group A is given in parentheses. 
TABLE  IV 
Removal of V.v.-adherent  Cells Reveals Suppressor  Activity in Spleen  Cells of Mice Injected 
with S3-SCSM and No Cy 
Donor mice given:*  Cells transferred* 
$3 PFC/spleen 0 
Exp. 1  Exp. 2 
A.  Mock SCSM  A  13,375 -  1,938  15,250 4- 1,950 
B.  S3-SCSM  B  9,163 + 2,097 (32)  14,250 4- 2,593 (7) 
C.  V.v. nonadherent of B  5,850 4- 1,660 (66)  3,500 4- 959  (77) 
D.  V.v. adherent of B  10,838 4- 1,990  (29)  12,063 4- 1,595 (21) 
E.  Cy + S3-SCSM  E  2,780 4- 121  (79)  4,410 4- 327  (71) 
* CAF~ mice were given  mock SCSM or S3-SCSM (no Cy) (groups A and B) or  100  mg/kg Cy 
followed 2 d later by S3-SCSM (group E). 8 d later, cells were transferred as indicated  to normal 
CAF~ mice which were then immunized with 0.6 t~g $3. 
* 5 x  106 cells transferred per recipient. 
Mean PFC/spleen  4- SEM of four to five mice per group determined 5 d after immunization.  The 
percent suppression relative to group A is given in parentheses. BRALEY-MULLEN  47 
cells from normal  mice given  S3-SCSM  (group B)  had  little  effect on  the  $3 
response.  The  V.v.-adherent  cells  obtained  from  these  spleen  cells  (group D) 
behaved similarly to the unfractionated cells whereas the V.v.-nonadherent cells 
(group C) suppressed the $3 response. In some experiments (e.g., Exp. 2 in Table 
IV), these V.v.-nonadherent cells suppressed the response as effectively as did 
spleen cells from Cy-treated mice injected with S3-SCSM (group E), although in 
the  majority  of experiments  the  Ts  induced  in  Cy-treated  mice  were  more 
effective (e.g., Exp.  1 in Table IV). These results suggest that contrasuppressor 
cells  in  mice  injected  with  S3-SCSM  act  by  preventing the  expression  of Ts 
activity  rather  than  by  preventing  the  activation  of Ts.  The  fact  that  both 
suppressor and contrasuppressor cells are present in spleen cells from mice given 
S3-SCSM  also  explains the  inability of unfractionated spleen  cells  from  these 
mice to abrogate the activity of Ts induced in Cy-treated mice (Table I), since 
there may be insufficient contrasuppressor cells to neutralize both populations 
of suppressor cells. It is also important to note that V.v.-adherent cells (group D 
in Table IV) injected alone do not augment the response to $3, indicating that 
these cells are not helper or amplifier cells. 
Contrasuppressor  Cells Are T  Cells.  Having demonstrated that V.v.-adherent 
cells from mice injected with S3-SCSM could abrogate the activity of Ts (Tables 
I and II), it was important to determine if these cells might be similar to the Tcs 
described by others (16).  Therefore spleen cells from mice injected 8 d  earlier 
with S3-SCSM were separated on V.v.  plates. The V.v.-adherent cells were then 
treated  with  anti-Thy-l.2,  anti-Lyt-l.2,  anti-Lyt-2.2  and  C,  or  with  C  alone 
before  transfer  with  Ts  to  recipient  mice  (Table  V).  As  shown  above  with 
untreated V.v.-adherent cells, the V.v.-adherent cells treated with C alone (group 
D) almost completely abrogated  the ability of Ts  to suppress the $3  response 
(group B).  Treatment of these cells with either anti-Thy-l.2  (group E) or anti- 
Lyt-l.2  (group F) and C  completely eliminated the ability of the V.v.-adherent 
TABLE  V 
Contrasuppressor  Cells Are Lyt-1 + T Cells 
Donor mice given:*  Cells transferred* 
$3 PFC/spleen  ! 
Exp.  1  Exp. 2 
A.  Cy +  mock SCSM  A  15,800 ___ 2,312  9,263 +  628 
B.  Cy +  S3-SCSM  B  5,550 +  9t0  (65)  2,750 +  380  (70) 
C.  S3-SCSM (no Cy)  C  ND  9,850 +  660  (0) 
D.  B  +  V.v. adherent of C  11,120 +  534  (30)  7,755 _+ 695  (16) 
(C treated) 
E.  B  +  V.v. adherent of C  2,650 _  539  (83)  2,700 +  398  (71) 
(a-Thy-l.2 +  C) 
F.  B  +  V.v. adherent oft  4,588 _  1,295 (71)  3,080 +  661  (67) 
(c~-Lyt-l.2 +  C) 
G.  B  +  V.v. adherent of C  6,562 +_ 1,327 (58)  4,887 +_ 1,140  (47) 
(a-Lyt-2.2 +  C) 
* See footnote *, Table I for experimental design. 
* In  groups D-G,  the  V.v.-adherent cells were  treated with antiserum and/or complement (C) as 
indicated before mixing with group B cells. 5 x  106 cells of each type were transferred per recipient. 
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cells to abrogate Ts activity, indicating  that the contrasuppressor cells are Lyt- 
1  + T  cells. Treatment with anti-Lyt-2.2 and C (group G) had a variable effect in 
these as well as several other experiments.  In general, contrasuppressor activity 
was only partially eliminated by anti-Lyt-2.2 so that it was not possible to draw 
any definite conclusion concerning  the presence or absence of Lyt-2 on these 
cells. It should be noted that the same anti-Lyt-2.2 serum used here does abrogate 
the activity of two different subsets of S3-specific Ts (9,  10) so that the results in 
Table V cannot be due to the inactivity of the antiserum used. It has been shown 
that  the Tcs described by Green et al.  (16,  21) have  I-J determinants  that are 
recognized  by some  monoclonal  anti-I-J  b reagents  (e.g.,  WF9.1.4)  but  not  by 
others (e.g.,  WF9.40.5) (D.  R. Green,  personal communication).  To determine 
if the Tcs described here also had similar I-J determinants,  BALB.B mice were 
injected with S3-SCSM.  8  d  later,  spleen cells from these mice were separated 
on V.v. The V.v.-adherent cells were treated with C alone or with the monoclonal 
anti-I-J b reagents WF9.1.4 or WF9.40.5 and C before transfer with Ts induced 
in BALB.B mice with Cy and S3-SCSM (Table VI). As noted above with CAF~ 
mice, spleen cells from BALB.B mice given Cy and S3-SCSM suppressed the $3 
response in recipient mice (group B vs. group A) while cells from mice given S3- 
SCSM and no Cy had no effect on the $3 response (group C). V.v.-adherent cells 
from these mice abrogated the activity of the Ts (group D). Treatment  of the 
V.v.-adherent  Tcs cells with  the monoclonal  WF9.40.5  had  little effect on Tcs 
activity  (group  E)  while  the  other  monoclonal  (WF9.1.4)  almost  completely 
eliminated the ability of these cells to abrogate Ts activity (group E vs. group B). 
Thus, Tcs induced by S3-SCSM apparently bear I-J determinants that are defined 
by the same monoclonal anti-I-J b reagent that eliminates Tcs in the SE system. 
Contrasuppressor  Cells Do Not Abrogate  the Activity  of S3-spec~c  Ts Induced In 
Vitro.  The results presented above demonstrate that Tcs induced by S3-SCSM 
TABLE  VI 
Tcs Bear I-J Determinants Defined by a Particular Monoclonal Anti4-J Reagent 
Donor mice given:*  Cells transferred  s 
$3 PFC/spleen  i 
Exp.  1  Exp. 2 
A.  Cy +  mock SCSM  A  17,513 +  1,562  19,650 _+ 3,465 
B.  Cy +  S3-SCSM  B  7,065 _+ 718  (60)  8,270 +  3,825 (68) 
C.  S3-SCSM (no Cy)  V.v. adherent of C  13,610 +  1,792 (22)  28,075 -+ 1,401 (0) 
D.  B  +  V.v.  adherent of C  13,195 -+ 1,320 (25)  28,860 _+ 4,683 (0) 
E.  B +  V.v. adherent of C  11,339___  1,453(35)  26,550-+6,819(0) 
(WF9.40.5 +  C) 
F.  B  + V.v.  adherent of C  5,690 +_ 1,044 (68)  10,110 -+ 2,875 (49) 
(WF9.1.4 +  C) 
* BALB.B mice were given 100 mg/kg Cy 2 d  before mock- or S3-SCSM (prepared using BALB.B 
SC)  (A  and B).  Group C  received  the  same  S3-SCSM  and  no  Cy.  8  d  later,  spleen  cells were 
transferred as indicated to normal BALB.B recipients which were immunized 4 h later with 0.6 ~g 
$3. 
In groups E and F, V.v.-adherent cells were treated with the indicated monoclonal anti-I-J  b and C 
before transfer. 5 x  106 cells of each type were transferred per recipient. 
0 Mean PFC/spleen _  SEM of four (Exp. 2) or six to nine (Exp.  1) mice per group determined 5 d 
after immunization. The percent suppression relative to group A is given in parentheses, BRALEY-MULLEN  49 
can abrogate the activity of S3-specific Ts induced in Cy-treated mice. We have 
also described and characterized (8, 9) a subset of S3-specific Ts that are induced 
by culturing spleen cells from mice injected with S3-SCSM in vitro with $3 and 
S3-SCSM. These in vitro induced Ts belong to a separate T  cell subset from the 
Ts induced in Cy-treated mice (9) and previous studies had indirectly suggested 
that the activity of these Ts could be neutralized by Lyt-1 + T  cells present in the 
same spleen cell populations (8). It was therefore of interest to determine directly 
if V.v.-adherent spleen cells from mice injected with S3-SCSM could also abrogate 
the  suppression  mediated  by the  in  vitro  induced  Ts.  Thus,  spleen cells from 
mice injected  with  S3-SC were cultured  with  either  mock SCSM  (controls)  or 
with $3 and S3-SCSM (Ts) as described in Materials and  Methods.  At the time 
of cell  transfer,  some  of the  Ts  were  mixed  with  an  equal  number  of V.v.- 
adherent cells from mice given S3-SCSM 8 d previously as a source of Tcs (see 
above). Cells were then transferred  to normal CAF1 mice that were immunized 
on  the  following  day  with  $3;  PFC  were  determined  5  d  later  (Table  VII). 
Clearly,  V.v.-adherent  cells had no effect on the ability of the in vitro induced 
Ts to suppress the $3 response (group B vs.  group C).  Because a  24-h interval 
between cell transfer and immunization  of recipients is required to demonstrate 
optimal suppression with the in vitro induced Ts, it was important to determine 
whether  the lack of effect of Tcs was due to a  real  difference in the ability of 
Tcs to abrogate  the activity of different subsets of Ts or whether Tcs activity 
could not be demonstrated  at all  when  the  interval  between cell  transfer  and 
immunization  was  24  h  rather  than  the  4-6  h  used  in  all  of the  previous 
experiments.  Thus,  mice were also injected with Cy and mock SCSM (control) 
or with  Cy and  S3-SCSM (Ts).  Ts induced  either  by this  latter  method or Ts 
induced  in  vitro  were  then  mixed  with  the  same  population  of V.v.-adherent 
TABLE  VII 
V.v.-adherent Cells from Mice Given S3-SCSM Have No Effect on S3-specific Ts Induced In 
Vitro 
Donors given (in vitro 
activation):  Cells transferred  ! 
$3 PFC/spleen  ! 
Exp. 1  Exp. 2 
A.  S3-SCSM (cultured with  A  10,320 ±  1,772  9,733 ± 
mock SCSM) 
(control)  ! 
B.  S3-SCSM (cultured with  B  5,462 +  877 (47)  1,375 ___ 
$3 + S3-SCSM) (Ts)  ! 
C.  S3-SCSM (no Cy)  B +  V.v. adherent of C  2,280 ±  448 (78)  1,725 ± 
D.  Cy +  mock SCSM*  D  ND  7,600 _ 
E.  Cy +  S3-SCSM*  E  ND  1,550 + 
F.  E + V.v. adherent of C  ND  5,413 + 
G.  S3-SCSM (no Cy)  G  ND  6,467 + 
2,799 
275  (86) 
319  (82) 
717 
202  (80) 
110  (29) 
1,o98 (15) 
* See footnote *, Table I. 
* 5 ×  106 cells of each type were transferred per recipient. Recipients were immunized 1 d after cell 
transfer. 
! Mean PFC/spleen _  SEM of four to five mice per group 5  d  after immunization. The percent 
suppression relative to the positive controls (group A or D) is given in parentheses. 
! See Materials and Methods for details of the induction of Ts. 50  CONTRASUPPRESSOR  T  CELL  REGULATION  OF  $3  RESPONSES 
spleen  cells from  mice  given  S3-SCSM  8  d  previously and  all  recipients  were 
immunized 24 h after cell transfer (Table VII, Exp. 2). The V.v.-adherent spleen 
cells had  no effect on the ability of the in vitro induced Ts to suppress the $3 
response (group C vs. group B), while the suppressive activity of the Ts induced 
in Cy-treated mice was largely abrogated by the same cell population. Thus Tcs 
appear to have different effects on different subsets of Ts. 
Discussion 
The  studies described here  have established  that  normal  mice injected  with 
S3-SCSM have in  their  spleens two types of regulatory T  cells, Ts (Table  IV) 
and  a  second T  cell  which  is  adherent  to  V.v.  and  which  acts  to abrogate  or 
contrasuppress the activity of S3-specific Ts (Table I). Because these two T  cell 
populations are both induced by S3-SCSM, unfractionated spleen cells from mice 
injected with S3-SCSM have little, if any, ability to suppress the antibody response 
to $3 (Table I, group C) or to contrasuppress the activity of Ts induced in Cy- 
treated mice (Table I,  group E).  By contrast,  separation  of the spleen cells on 
V.v.  reveals  suppressor  activity  in  the  V.v.-nonadherent  cells  (Table  IV)  and 
contrasuppressor  activity  in  the  V.v.-adherent  cells  (Table  I,  group  G).  The 
finding that  S3-SCSM activates Tcs in addition  to Ts in normal  mice provides 
an explanation  for our inability to detect Ts in such spleens in these as well as 
previous studies (8-10). As shown previously, S3-specific Ts are readily detected 
when donor mice are given Cy before the injection of S3-SCSM (10 and Table 
I, group B). We previously hypothesized (10) that  Cy acted by eliminating  cells 
which  interfered  with  Ts  activity.  Direct  evidence  for  that  hypothesis  was 
obtained  in  the  present  studies  since  V.v.-adherent  cells from  Cy-treated  mice 
given  S3-SCSM  were  unable  to  abrogate  Ts  activity,  whereas  the  same  cell 
population obtained from mice not given Cy did abrogate Ts activity (Table III). 
The finding that cells with contrasuppressor activity are Cy sensitive is consistent 
with  the  results of a  recent study which  showed that  a  Cy-sensitive T  cell can 
abolish the activity of a Cy-resistant subset of Ts. Both of these cells were induced 
by injection  of trinitrophenyl  (TNP)-SC  into the anterior  chamber  of the  eye 
(17, 18). Moreover, a serum factor with antisuppressor activity has been recently 
described and this factor was not produced by Cy-treated mice (19). 
Gershon et al. (12) first showed that T  cells with contrasuppressor activity can 
regulate  the  in  vitro  antibody  response  to  SE.  They  defined a  Tcs  circuit  in 
which Lyt-2  + T  cells (contrasuppressor  inducers) acted on Lyt-l+2  + transducer 
cells which  in  turn  activated  Lyt-l+2  -  contrasuppressor  effector cells (12,  16, 
20).  In  their  system (16), contrasuppressor  effector cells were shown to act on 
helper T  cells (Th) to render them resistant to Ts signals. The contrasuppressor 
cell we describe here has also been shown to be a T  cell and to be Lyt-1 + (Table 
V). Whether the Tcs described here is a Lyt-l+2  -  contrasuppressor effector cell 
or a Lyt-I +2 + T  cell perhaps similar to the contrasuppressor transducer cell (12, 
16, 20) is not known, since treatment  with anti-Lyt-2 and C partially but never 
completely eliminated  contrasuppressor  activity (Table V).  The  Tcs described 
here also were found to bear I-J determinants  (Table VI) similar or identical to 
the I-J determinants  found on Tcs that  regulate responses to SE (D.  R. Green, 
personal  communication),  which  suggests  their  similarity  to  Tcs  described  in BRALEY-MULLEN  51 
other systems (12, 20, 21). However, while the Tcs described here may be similar 
to those described by Green et al.  (16,  21),  it is  unlikely that the Tcs in  our 
system act by making Th resistant to Ts signals (16), since the antibody response 
to $3 presumably does not involve Th interaction with B cells (22). The mecha- 
nism by which Tcs regulate the $3 response is not known at this time. Two likely 
possibilities are that Tcs interact directly with Ts and neutralize their activity or 
that Tcs somehow make S3-specific B cells resistant to Ts signals.  Studies are 
currently in  progress to  determine which,  if either,  of those mechanisms are 
operative in this system. 
An unexpected observation in these studies was the finding that the Tcs which 
consistently abrogated the suppression  mediated by S3-specific Ts induced in 
Cy-treated mice injected with S3-SCSM had no effect on S3-specific Ts induced 
in vitro (Table VII). Previous studies have established that both of these Ts are 
$3 specific and are Lyt-l-2  ÷, I-J ÷ T  cells, but differ in several other properties, 
indicating that they are separate subsets of Ts (9). The Ts induced by S3-SCSM 
in Cy-treated mice bind to S3-SCSM but not to anti-S3-coated plates (10), appear 
to directly suppress S3-specific B cells (9), and are apparently not V, restricted 
(Braley-Mullen, unpublished results). By contrast, the in vitro induced Ts bind 
to  anti-S3-coated  plates  (9),  require a  Cy-sensitive T  cell in  the recipient to 
mediate suppression (9), and are V. restricted (unpublished results). These later 
Ts are thus similar to the second order Ts (Ts2) described by others (reviewed 
in 23). Although it has been suggested that all types of Ts may not be regulated 
by  cells  in  the  contrasuppressor  circuit  (21),  considerable  indirect  evidence 
suggests that the in vitro induced Ts are regulated by contrasuppressor cells. For 
example, our initial  studies indicated that suppression  mediated by these cells 
was lost if supraoptimal numbers of T  cells were transferred to recipient mice 
(8),  suggesting that cells which could interfere with Ts were also present in the 
cultured spleen cell population. In addition, the degree of suppression obtained 
with low numbers of transferred cells was often, although not always, increased 
when cells were treated with anti-Lyt-l.2 and C before transfer (9).  Moreover, 
the need to culture the cells to obtain detectable Ts suggests that at ]east the 
precursor of the Ts is influenced by contrasuppressor cells, the activity of which 
might be diminished or lost during culture. The finding that Tcs obtained from 
mice injected 8 d  earlier with S3-SCSM do not affect the activity of the in vitro 
induced Ts suggests the possibility that, in spite of the indirect evidence discussed 
above, this Ts subset is not affected by Tcs. Alternatively, it is possible that more 
than one subset of Tcs exists and that the Tcs detected in mice injected 8  d 
previously with  S3-SCSM  do  not affect all  subsets of Ts.  Recent evidence in 
another system (24) indicates that distinct subsets of Tcs regulate suppression 
mediated by distinct subsets of Ts, so that this is not an unlikely possibility. It is 
also posible that only the precursors of the in vitro induced Ts are susceptible to 
Tcs so that an effect of Tcs might have been observed if the Tcs had been added 
at the initiation of culture. Studies currently in progress should help to resolve 
these questions. 
The specificity of Tcs in the SE system has been reported (12, 21) to be less 
stringent than that of Ts or Th in that the activity of a Tcs factor induced by SE 
could be adsorbed by other types of erythrocytes (12, 21). Similarly, Rohrer and 52  CONTRASUPPRESSOR  T  CELL  REGULATION  OF  $3  RESPONSES 
Kemp  (24)  have  shown  that  at  least  one  Tcs  subset  is  highly  cross-reactive 
although another is SE specific. Our studies indicate that the Tcs described here 
are induced  by S3-SCSM but not by another TI antigen,  PVP-SCSM, and that 
the  Tcs are  not  present  in  normal  mice  (Table  II).  The  fact  that  PVP-SCSM 
does not activate the Tcs which regulate the $3 response suggests that  Tcs are 
not entirely antigen nonspecific, but our data do not exclude the possibility that 
they could be activated by more closely related antigens such as other pneumo- 
coccal polysaccharides. 
Finally,  it  is  important  to emphasize  that  the  Tcs described here  do not by 
themselves have any discernible effect on the $3 response (Table IV, group D). 
This strongly suggests that Tcs are not identical to Ta, which have been shown 
to interact antagonistically with Ts to regulate the $3 response (3,  11).  Athough 
Tcs  and  Ta  are  both  Ly-1 ÷ cells  (Table  V  and  reference  11),  Ta  markedly 
augments  the  antibody  response  to  $3  when  injected  into  normal  mice  (11) 
whereas Tcs clearly do not have this effect. Thus the antibody response of mice 
to a  so-called  TI  antigen  such as  $3  can  be influenced  by multiple  subsets of 
regulatory T  cells that can now be separated both functionally and physically so 
that their properties and roles in the immune response can be studied in detail. 
It will be of particular  interest to determine if Tcs such as those described here 
can be activated by free $3.  If so,  Tcs may prove to be important  in enabling 
polysaccharide  antigens  such  as $3  to elicit a  positive immune  response,  since 
these types of antigens tend to induce tolerance very effectively. (2, 5, 22). It has 
previously (25) been suggested that the activation of T  cells which can block Ts 
activity may be essential  if an  immune response  is to take place.  Tcs have also 
been shown (26) to be capable of interfering with tolerogenic signals in vivo and 
are important in allowing neonatal cells to exhibit positive immune function (16, 
21). Clearly further studies will be required to fully define the role of Tcs in the 
regulation of the immune response to $3 as well as other types of antigens. 
Summary 
A  soluble membrane  component  of type  III  pneumococcal  polysaccharide- 
coupled  spleen  cells (S3-SCSM)  induces  S3-specific suppressor  T  cells  (Ts)  in 
mice. These Ts can be detected only if mice are pretreated with cyclophospha- 
mide (Cy) or if cells adherent  to the lectin  Vitia villosa are removed from  the 
spleen cell population prior to transfer. The V. villosa-adherent spleen cells from 
mice injected with S3-SCSM could abrogate suppression mediated by Ts induced 
by S3-SCSM in Cy-treated mice. The V. villosa-adherent contrasuppressor cells 
were shown to be T  cells that were I-J + and of the Lyt-1 phenotype. Contrasup- 
pressor T  ceils (Tcs) were not present in V. villosa-adherent spleen cell fractions 
obtained  from  normal  mice,  from  mice  injected  with  polyvinylpyrrolidone- 
coupled spleen cells, or from Cy-treated mice injected with S3-SCSM, i.e., mice 
in  which  Ts activity is dominant.  The  V.  villosa-adherent  cells that  abrogated 
the  activity  of Ts  induced  by S3-SCSM  in  Cy-treated  mice  did  not  abrogate 
suppression mediated by a different subset of S3-specific Ts, suggesting that the 
Tcs described here do not have activity against all Ts subsets. The ability of S3- 
SCSM to activate Tcs in normal  mice provides an explanation  for the inability 
to detect S3-specific Ts in several previous studies. BRALEY-MULLEN  53 
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